Clinical Trial Update: Long-term Extension Study Evaluating Extended Release Ropinirole XL (Formerly Referred to as Ropinirole CR) in Patients Who Already Completed Either Study 167 or 164 [Phase 3]

View source ↗

Summary

Long-term extension study evaluating extended-release ropinirole in Parkinson disease patients who completed prior Phase 3 trials; results from the extension we…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Ropinirole XL (ropinirole)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Parkinson Disease | Phase 3 | Status: COMPLETED | Results posted: 2010-04-21